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Abstract
Background: Postnatal depression has received considerable research and clinical attention,
however anxiety and stress in the postpartum has been relatively ignored. Along with the
widespread use of the Edinburgh Postnatal Depression Scale (EPDS), depression has become the
marker for postnatal maladjustment. Symptoms of anxiety tend to be subsumed within diagnoses
of depression, which can result in anxiety being minimized or overlooked in the absence of
depression. Some researchers have identified the need to distinguish between postnatal depression
and anxiety, and to discern cases where depression and anxiety co-exist. The aim of this study was
to assess the prevalence of postnatal distress using the EPDS and the Depression Anxiety Stress
Scales (DASS-21).
Method: As part of a larger cross-sectional study, the EPDS and DASS-21 were administered to
a convenience sample of 325 primiparous mothers, who ranged in age from 18 to 44 years (M =
32 years). Recruited through mother's groups and health centres in Melbourne Australia, inclusion
was limited to mothers whose babies were aged between 6 weeks and 6 months. Analyses included
comparisons between the classifications of women according to the EPDS and the DASS-21, and
an exploration of the extent to which the EPDS identified anxious-depressed women.
Results: The EPDS identified 80 women (25%) as possibly depressed (using a cut-off of over 9), of
which the DASS-21 corroborated 58%. In the total sample, 61 women (19%) were classified by the
DASS-21 to be depressed. Using broader criteria for distress, it was revealed by the DASS-21 that
a further 33 women (10%) showed symptoms of anxiety and stress without depression. A total of
41 women (13%) had symptoms of anxiety either in isolation or in combination with depression.
The DASS-21 identified 7% of the sample as being both anxious and depressed. This at-risk sub-
group had higher mean EPDS and DASS-depression scores than their depressed-only counterparts.
Conclusion: The prevalence of anxiety and stress in the present study points to the importance
of assessing postnatal women for broader indicators of psychological morbidity than that of
depression alone. The DASS-21 appears to be a useful instrument for this purpose.
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Background
Although new motherhood is generally regarded as a joy-
ous and meaningful experience, this period of transition
involves a multitude of abrupt changes, and is recognized
as a stressful life event [1-4]. It has been reported that
around 13% of childbearing women suffer from postnatal
depression (see meta-analysis by O'Hara & Swain [5]).
The ramifications of undetected or untreated postnatal
depression can be far-reaching for the mother, her infant,
and her relationship with her partner [6-8].
Postnatal depression is the most prevalent of the postpar-
tum mood disorders, and has therefore received the pre-
dominance of research attention in recent years (see Pope
[9] for a review). However, several authors have pointed
to the importance of distinguishing between postnatal
depression and postnatal anxiety [7,9-11]. It is widely
acknowledged that anxiety and depression (both as affec-
tive states and as clinical disorders) commonly co-exist
[7,12]. This is also the case in the postpartum [13-16].
However, anxiety in the postpartum is generally sub-
sumed within diagnoses of depression [9,17] as shown by
the widespread use of the Edinburgh Postnatal Depres-
sion Scale (EPDS) in postnatal research [7]. Green [14]
asserted that the concept of depression might in fact limit
our understanding of postnatal distress, suggesting that
broader indicators of negative mood need to be consid-
ered.
Milgrom, et al. [15] pointed to the importance of distin-
guishing anxiety from depression in order to provide
appropriate treatments that target the symptoms and aeti-
ology of anxiety specifically. This notion is supported by a
study by Matthey et al. [7] that found that not all anxious
mothers were depressed. Moreover, research with non-
postpartum populations has shown that comorbidity of
anxiety and depression – anxious depression – manifests
more severe symptoms [18], is more difficult to treat than
each disorder alone [19], is associated with poorer acute
and long-term outcome [18], increases the risk for suicide
[20], and requires specific treatment strategies for both
sets of symptoms [19]. Matthey, et al. [7] pointed to the
"hierarchical diagnostic custom" that requires depression
to take precedence even when anxiety symptoms are a
prominent feature (p. 144). This focus on depression can
result in cases of anxiety (without depression) being
undetected, and untreated. Similarly, in cases where
depression and anxiety co-occur (anxious-depression), there
is a risk that treatment strategies focus on the depressive
symptoms, at the preclusion of specific treatments for the
symptoms of anxiety. Ross, et al. [16] noted the impor-
tance of determining whether anxiety symptoms are part
of a primary depression, or whether they form their own
clinical entity.
Heron, et al. [11] suggested that anxiety may be a precur-
sor to depression as a result of altered physiological path-
ways, or from the consequences of failing to manage
stress. According to Lovibond and Lovibond [21], stress is
a distinct negative emotional state that involves chronic
arousal and impaired function. In a sample of new moth-
ers, Terry, et al. [4] found evidence linking levels of stress
and coping responses to depressive symptomatology.
Measurement of postnatal depression
Several depression rating scales have been developed and
validated on non-postpartum populations. However, the
validity of these scales has been questioned in terms of
their use in the postpartum, because some items (eg. lack
of sleep, listlessness, weight loss, and poor concentration)
are viewed as part of the 'normal' realm of being a nursing
mother, rather than being due to depression [15,22].
Scales that include such symptoms may artificially inflate
women's scores on depression, increasing the risk of false
positives.
As a result of the potential confounding factors of some
depression scales for the postpartum, the Edinburgh Post-
natal Depression Scale (EPDS) was developed in 1987 by
Cox, Holden, & Sagovsky [23]. The EPDS has been vali-
dated in numerous studies (see Pope [9] for a review), and
has proven to be a simple, user-friendly, and reliable
instrument for screening women for postnatal depression
[22-24] in both clinical practice [15,25-29] and in
research [30-34]. Although originally designed to measure
depression, it has been suggested in a number of recent
factor analytic studies [16,35] that the EPDS also taps into
symptoms of anxiety.
Most studies use an EPDS score of over 12, which suggests
a likelihood of depression [9]. However some researchers
suggest a lower cut-off of over 9 to more sensitively detect
women with depressive symptomatology [36]. Irrespec-
tive of the cut-off used, a positive identification on the
EPDS flags the need for further assessment. Because the
EPDS does not discriminate levels of depression, addi-
tional information is required to meet diagnostic criteria
for depression. Several studies have used the Beck Depres-
sion Inventory (BDI), in conjunction with the EPDS, for
the purposes of assessing the severity of depression in
postnatal women [9]. Although it has been demonstrated
that the BDI is a psychometrically robust instrument, its
use in the postpartum calls for careful interpretation [37].
It has been noted that somatic symptoms that reflect the
normal aspects of postnatal life (eg. lack of sleep, tired-
ness, and weight change) may inflate depression scores on
the BDI [15,37], and that episodes of mild depression
may not be detected by the BDI at the subclinical level in
postnatal women [37].BMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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The Depression Anxiety and Stress Scales (DASS)
Empirical analyses in both non-clinical and clinical sam-
ples, have shown that conventionally regarded core symp-
toms of depression, such as sleep disturbance, changes in
appetite, weight change, and loss of libido, are weak
markers for the syndrome of depression [21]. Following
extensive psychometric evaluations to maximally discrim-
inate between depression and anxiety, Lovibond and
Lovibond's 'Depression, Anxiety and Stress Scales' (DASS)
[38], rejected items that have been identified as potential
confounders within the BDI for use in the postpartum.
These items included disturbance of sleep, appetite/
weight loss, tiredness, lack of energy, and poor concentra-
tion [38]. Scale development of the DASS also yielded a
third group of items that characterized a chronic non-spe-
cific arousal that the authors termed "stress" [38,39]. The
DASS has been found to reliably distinguish between the
symptoms of depression (dysphoric mood), anxiety
(physiological arousal), and stress (psychological tension
and agitation) [40], in both non-clinical [38-40] and clin-
ical samples [40,41]. The authors recommend the use of
the DASS in combination with other diagnostic informa-
tion (such as clinical interviews).
Broadening the criteria for postnatal distress
The postpartum period arguably represents one of the
most important life stages for which the accurate detec-
tion and treatment of psychological distress is required.
The transition to new motherhood has been associated
with emotional distress in up to 30% of women [42],
however depression has 'trumped' in terms of represent-
ing the diagnostic benchmark for postnatal maladjust-
ment [7]. Given the potential for untreated postnatal
distress to adversely affect the ongoing well-being of the
mother and her infant, it seems pertinent to distinguish
women's negative emotional states, in order to appropri-
ately treat their unique symptoms. In order to represent a
more complete picture of affective disturbance following
childbirth, we suggest that the term postnatal distress be
used to identify not only depression, but anxiety, and
stress. The DASS was selected in the present study for a
number of reasons: (1) its ability to identify these three
negative emotional states as separate phenomena, (2) its'
capacity to identify comorbidity of these negative emo-
tional states, (3) the fact that it does not include the
potential confounding factors for which other depression-
severity scales have been criticized, and (4) its ability to
identify mild symptoms of each negative affective state, in
order to more fully identify women who might be dis-
tressed.
Aims of the present study
According to Lovibond and Lovibond [21], stressful life
events have the potential to precipitate episodes of anxiety
and depression, and to "lead to a characteristic stress
response involving chronic arousal and impaired func-
tion" (p. 335). Given that new motherhood holds the
potential to be a stressful life event [2-4], and to elicit var-
ious cognitive-affective symptoms [9], it seems reasonable
to propose that the DASS be used to assess the negative
emotional states of, not only depression, but of anxiety
and stress in postnatal women.
The primary aims of the present study were to assess the
prevalence of postnatal distress in a sample of postnatal
women, and to provide a preliminary investigation into
the potential use of the EPDS in conjunction with the
DASS. To this end, both the EPDS and the DASS were
administered to this population. Firstly, the EPDS and the
DASS depression scales were used to reflect the prevalence
of postnatal depression in the total sample, and the extent
to which these two scales corroborated their classifica-
tions. Secondly the prevalence of anxiety and stress was
explored to form the basis of a broader concept of postna-
tal distress. Using a conceptualization of postnatal distress to
include depression, anxiety and stress, the present study
assessed the extent to which anxious and stressed mothers
might have otherwise been missed using criteria for
depression only (using both the EPDS and the DASS).
Thirdly, the comorbidity of depression, and anxiety was
examined, with particular interest in the sub-group of
women who had a combination of depression and anxi-
ety (anxious-depression) and the extent to which the EPDS
detected these cases.
Methods
Participants
As part of a larger cross-sectional study (on first-time
mothers' experiences of motherhood), a convenience
sample was obtained in Melbourne, Australia, by inviting
primiparous women to voluntarily participate in the
study. The study was entitled "Factors associated with
first-time mothers' experience of motherhood". Informa-
tion posters, along with copies of the questionnaires (with
reply paid envelopes), were placed in maternal and child
health centres, mothers' groups, and doctors' waiting
rooms. Women were invited to complete a questionnaire
and return it via post, with no identifying information
included. In order to reduce the potential confounds of
additional children, criteria for inclusion limited partici-
pants to first time mothers with no step or foster children.
Similarly, to reduce the variability of different stressors
impacting women at later stages of infant development,
participants were required to be between 6 weeks and 6
months postnatal. This time-period was also consistent
with other research that has found that half the cases of
postnatal depression occur in the first three months, and
three quarters of cases by six months postpartum [43]. The
study was approved by the Swinburne University of Tech-
nology Ethics Committee.BMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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A total of 325 women participated in this study ranging in
age from 18 to 44 years, with a mean age of 32 years (SD
= 4.6). The age of women's babies at the time of complet-
ing the questionnaire ranged from 6 weeks to 6 months,
with a mean age of 13 weeks (SD = 5.0). The majority of
women (94%) were married (n = 248) or in a defacto rela-
tionship (n = 59), with 9 women (2.8%) in a non-cohab-
iting relationship, 5 women (1.5%) who were single, 2
women (0.6%) who were divorced, and 1 woman (0.3%)
who was widowed. In relation to educational level, 103
women (31.9%) reported having had no tertiary educa-
tion, 107 women (33.1%) reported having completed
undergraduate university degrees, and 113 women
(34.8%) reported having completed postgraduate univer-
sity degrees.
Measures
Depression Anxiety Stress Scales (DASS-21)
The DASS consists of three self-report scales that have
been designed to measure the negative emotional states of
depression, anxiety and stress [38]. Lovibond and Lovi-
bond [38] reported that the depression scale measures
"...dysphoria, hopelessness, devaluation of life, self-dep-
recation, lack of interest/involvement, anhedonia, and
inertia"; the anxiety scale measures "autonomic arousal,
skeletal muscle effects, situational anxiety, and subjective
experience of anxious affect"; and the stress scale meas-
ures "difficulty relaxing, nervous arousal, and being easily
upset/agitated, irritable/over-reactive and impatient"
(p.1).
Initially normed on first-year university students [38], the
DASS has also been normed on clinical samples revealing
adequate psychometric properties [21]. Exploratory factor
analyses showed a first order three-factor structure of
depression, anxiety and stress [38,41]. Convergent and
divergent validity for the DASS has been demonstrated
whereby the DASS depression scale correlated strongly
with the BDI-II (r = .74), and the DASS anxiety scale was
highly correlated with the Beck Anxiety Inventory (BAI) (r
= .81) [21,38].
The DASS-21 is a brief 21 item version of the full DASS,
which originally consisted of 42 items. Each of the three
DASS-21 scales contains seven items representing the
dimensions of depression, anxiety and stress. Participants
are asked to rate the extent to which they experienced each
state over the past week on a 4-point likert rating scale.
Sub-scale scores are derived by totaling the scores. No
items are reverse scored. Scores for each sub-scale are mul-
tiplied by two to ensure consistent interpretation with the
longer 42 item version [38]. The DASS manual [38] pro-
vides a series of cut-off values to classify individuals into
severity rating categories. These severity ratings are based
on percentile scores, with 0–78 classified as 'normal', 78–87
as 'mild', 87–95 as 'moderate', 95–98 as 'severe', and 98–100
as 'extremely severe' [38]. Lovibond and Lovibond's [38]
reported alpha values for the DASS-21 from a student
sample (N = 717) were .81 for depression, .73 for anxiety,
and .81 for stress. In a clinical sample, Clara, Cox, and
Enns [44] reported high levels of internal consistency for
the DASS-21 with alpha values of .92 for depression, .81
for anxiety, and .88 for stress. Internal consistency in the
present study was explored for each scale of the DASS-21,
and Cronbach alpha coefficients were adequate: Depres-
sion (.84), Anxiety (.77) and Stress (.86).
Edinburgh Postnatal Depression Scale (EPDS)
The EPDS has been designed to screen postnatal women
for the likelihood of postnatal depression [23]. The 10-
item scale assesses symptoms of anhedonia and reactivity,
self-blame, anxiety, panic, coping, insomnia (due to
unhappiness), sadness, tearfulness and self-harm [22].
The EPDS excludes somatic symptoms such as fatigue and
change in appetite, which may occur normally in the post-
partum, and which may otherwise potentially not dis-
criminate depressed from non-depressed women.
This 10-item scale includes questions such as "I have been
able to laugh and see the funny side of things" and "I have
blamed myself unnecessarily when things went wrong".
Respondents indicate on a four-point likert scale, the
response that best describes the way they have been feel-
ing over the past seven days. Items are scored from 0 to 3
with a maximum total score of 30. The EPDS has been
used extensively as a screening tool in clinical practice and
in research into various aspects of postnatal depression
[9]. Good psychometric properties, including sensitivity
and specificity, have been reported for the EPDS using a
cut-off of 12 [20,22,23,45]. Some authors have recom-
mended a cut-off of over 9 on the EPDS to increase its'
sensitivity in community screening [34,46], despite the
fact that many of the women scoring above this threshold
may not meet the criteria for clinical depression. This
lower threshold has resulted in reported sensitivity values
of 84–100% and specificity values of 82–88% [45,46].
The reliability and validity of the EPDS has been well-doc-
umented [37]. Cronbach's alpha for the EPDS in the
present study was .88.
Results
Prevalence of depression according to the EPDS and the 
DASS
In the present sample of postnatal women (N = 325), the
mean score on the EPDS was 6.94 (SD = 4.8). The EPDS
identified 36 women (11.3%) to have a score above the
commonly recommended cut-off of 12 [23]. However,
using a more sensitive cut-off of 9 [34,46] 80 women
(25%), were identified as likely to be depressed. From this
point on in the results section, women identified as likelyBMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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to be depressed using a cut-off of over 9 on the EPDS, will
be referred to as likely depressed. Those women scoring 9 or
less on the EPDS will be referred to as unlikely depressed.
Consistent with common clinical practice, additional
information is required to assess the severity of depression
for the women identified as likely depressed on the EPDS.
In this study the DASS-21 depression scale was used for
this purpose. The mean DASS-21 depression score was
5.10 (SD = 6.4), the mean DASS-21 anxiety score was 3.33
(SD = 5.3) and the mean DASS-21 stress score was 10 (SD
= 8.1). The recommended cut-offs in the DASS manual
[38] were utilized, resulting in five severity categories: nor-
mal, mild, moderate, severe, and extremely severe. Women
scoring in the normal category on depression were referred
to from this point on as non-depressed, and women scoring
in the mild, moderate, severe and extremely severe categories
were referred to as depressed. On the DASS-21, the number
and percentage of women identified in this sample as
depressed was 61 (19%).
An exploration was conducted of the two depression
measures in terms of cross classifications. These findings
are presented in Figure 1.
Prevalence of postnatal distress according to the DASS, 
and the EPDS
The present study proposed a broader classification for
assessing postnatal distress, over and above that of the
usual focus on depression. To this end, the DASS-21 was
used to assess the severity levels of not only depression,
but of anxiety and stress as well. According to the recom-
mended cut-offs in the DASS manual [38] scores were
classified into severity categories of normal, mild, moderate,
severe, and extremely severe, with respect to depression, anx-
iety and stress. Women who scored in the normal range on
depression, anxiety or stress, are referred to here as non-
depressed,  non-anxious  and  non-stressed  respectively.
Women who scored in the mild to extremely severe ranges,
were referred to as depressed,  anxious  or stressed  respec-
tively.
The first step was to investigate the 80 women who were
identified by the EPDS as likely depressed, and to present
the corresponding DASS-21 classifications for these
women. Figure 1 presents the typical clinical pathway,
whereby once the 80 women had been identified as being
likely candidates for depression (on the EPDS), these
women would have been assessed further. According to
DASS-21 classifications for women identified as depressed on the EPDS Figure 1
DASS-21 classifications for women identified as depressed on the EPDS.
N = 325
EPDS
Unlikely
depressed
n = 240 (73.8%)
DASS
Depressed
n = 46 (58%)
DASS
Non-depressed
n = 34 (42%)
EPDS
Likely
depressed
n = 80 (24.7%)
DASS
Depressed
n = 14 (5.8%)
DASS
Missing data
n = 1 (0.4%)
EPDS
Missing
data
n = 5 (1.5%)
DASS
Non-depressed
n = 225 (93.8%)
DASS
Anxious
n = 10 (12%)
DASS
Stressed
n = 5 (6%)
Further assessment for
anxiety and stress
DASS
No classification
n = 19 (24%)BMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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the DASS-21, 46 women were classified as depressed, and
34 were not. Applying the broader criteria of anxiety and
stress using the DASS-21, it was revealed that of the 34
women identified by the EPDS as likely depressed, but not
corroborated by the DASS-21 depression scale as
depressed, 10 women were identified as anxious, and 5
women as stressed. Nineteen women received no classifica-
tion on the DASS-21 (see Figure 1).
The next step was to investigate the prevalence of depres-
sion, anxiety and stress for the total sample, using the
DASS-21. Women who scored in the mild, moderate, severe
and extremely severe categories on at least one DASS-21
scale (depression, anxiety, or stress) were considered to be
postnatally-distressed. Using these criteria, 94 women
(29%) in the total sample were identified as postnatally-
distressed. Figure 2 presents the number and percentages of
women who were depressed, anxious  and stressed  in the
total sample.
According to the DASS-21, an additional 33 women
(10%) over and above the 61 women (19%) identified as
depressed in the total sample, were classified as postnatally
distressed  (i.e., with classifications of anxiety and/or
stress). In other words, had depression been the only cri-
terion for which the present sample had been assessed, 33
distressed  women (a further 10% of the total sample)
would have been missed using the DASS-21 depression
scale alone.
Returning to the EPDS classifications, of the 80 women
identified by the EPDS as likely depressed, 46 women
(58%) were correspondingly identified as depressed using
the DASS-21 depression scale. However of these 80 EPDS-
identified women, 15 (19%) were not corroborated by the
DASS-21 as being depressed, which may have resulted in
no further assessment if depression had been the sole cri-
teria. With the inclusion of the DASS-21 anxiety and stress
scales, these 15 distressed women were able to be identi-
fied, whereby 10 women were found to be anxious, and 5
women were identified as stressed. Of the 240 women clas-
sified by the EPDS as not likely to be depressed, the DASS-21
revealed that 14 women (6%) were classified as depressed.
Similarly, of the 240 women identified by the EPDS as not
likely to be depressed, 8 women (3%) were anxious, and 10
women (4%) were stressed.
These findings indicate that despite the sensitive EPDS
cut-off of over 9, 14 depressed women were not identified
by the EPDS as likely to be depressed, and 18 women who
were postnatally distressed would not have been assessed
further, had the EPDS been the initial screening tool used.
With respect to the presence of anxiety in the total sample,
41 women (13%) had symptoms of anxiety either in iso-
lation or in combination with depression and/or stress.
This finding further supports the need to include anxiety
in the assessment of postnatal women.
Comorbidity of depression, anxiety and stress
Of particular interest in the present study was the sub-
group of women who had both symptoms of depression
and of anxiety (anxious-depression). Figure 3 shows the
classifications for women in the present sample, accord-
ing to both EPDS and the DASS-21, with anxious-depressed
Classification of women on the DASS-21 Figure 2
Classification of women on the DASS-21.
N = 325
DASS
Distressed
n = 94 (28.9%)
DASS
Non-distressed
n = 230 (70.8%)
DASS
Missing data
n = 1 (0.3%)
DASS
Depressed
n = 61 (64.9%)
DASS
Anxious
n = 18 (19.1%)
DASS
Stressed
n = 15 (16.0%)BMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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women reflected as a separate group from the women
who were just depressed.
Figure 3 shows that out of the total sample of women, the
DASS-21 found 38 women (12%) to be depressed, 23
women (7%) to be anxious-depressed, 18 women (6%) to
be anxious (without depression), and 15 women (5%) to
be stressed (without depression or anxiety). An interesting
finding was the capacity of the EPDS to detect anxious-
depressed women more accurately than it failed to detect
anxious-depressed women. In order to explore this finding
statistically, four groups of women were generated accord-
ing to their classification on the DASS-21. This was done
to determine whether there were differences among these
four groups of women on EPDS scores. The four groups
were the depressed group (n = 37), the anxious-depressed
group (n = 23), the anxious group (n = 18) and the stressed
group (n = 15). Because of the negative skew in the distri-
bution of scores on the EPDS (the dependent variable), a
non-parametric Kruskal-Wallis test was used. Results indi-
cated a statistically significant difference among the
groups. Inspection of the mean ranks revealed that the
highest scores on the EPDS were found for the anxious-
depressed  group (mean rank = 70.83), followed by the
depressed group (mean rank = 44.35), the anxious group
(mean rank = 38.69) and the stressed group (mean rank =
26.97) (chi square = 28.42, df = 3, p < .001). These find-
ings point to the capacity of the EPDS to detect anxious-
depression.
In order to further interpret these findings, the DASS-21
severity categories (i.e., mild,  moderate,  severe, and
extremely severe) were explored for each defined group of
women (i.e., depressed,  anxious-depressed,  anxious, and
stressed), with the corresponding number of women who
received an EPDS classification (i.e., likely depressed and
unlikely depressed) (see Table 1).
The most notable findings in Table 1 are that the EPDS,
despite the sensitive cut-off of over 9, did not detect 10
women who had mild  symptoms of depression, and 2
women who had moderate symptoms of depression. The
EPDS identified almost all of the anxious-depressed
women, except for 2 women, both of whom had DASS-21
scores that were moderate on depression and severe on anx-
iety. Interestingly, the EPDS (which is a tool to detect the
likelihood of depression) identified 10 out of 18 women
who were anxious (but not depressed). Similarly, the
EPDS detected 5 cases of stress  (without depression).
Inspection of Table 1 suggested that the anxious-depressed
Classification of women on both the DASS-21 and EPDS Figure 3
Classification of women on both the DASS-21 and EPDS.
N = 325
DASS
Distressed
(at least one DASS
classification)
n = 94
Depressed (n=38)
Anxious-Depressed (n=23)
Anxious(n=18)
Stressed (n=15)
EDPS
Unlikely
depressed
n = 240
Depressed (n=12)
Anxious-Depressed (n=2)
Anxious(n=8)
Stressed (n=10)
Total number of
distressed women
missed
n = 32
EDPS
Likely
depressed
n = 80
Depressed (n=25)
Anxious-Depressed (n=21)
Anxious(n=10)
Stressed (n=5)
Total number of
distressed women
detected
n = 61BMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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group of women had more severe scores on DASS-21
depression than the women who were depressed (without
anxiety). In order to explore this statistically, a Mann-
Whitney U test was conducted to determine whether there
was a difference between these two groups on DASS-21
depression scores. A significant difference was found
between these two groups whereby the anxious-depressed
group (mean rank = 42.02) had higher scores on DASS-21
depression than the depressed (only) group (mean rank =
24.33: Z=-3.84, p < .001).
Discussion
The present study proposed a broader classification for
postnatal distress, to include measures of not only depres-
sion, but of anxiety and stress as well. Some authors have
suggested that many women experience distress in the
postpartum that is potentially missed using the criteria for
depression alone [7,17]. These authors have stated that it
is incorrect to conclude that women are functioning well
just because they do not fit the criteria for depression. This
notion is particularly relevant in light of the potential
adverse consequences of untreated distress in new moth-
ers at this critical time.
Applying a broader conceptualization of postnatal distress
in the present study, 94 women (29% of the total sample)
were found to have at least one classification of depres-
sion, anxiety or stress, in the mild,  moderate,  severe  or
extremely severe categories on the DASS-21 [38]. This find-
ing is consistent with Johnson et al. [42], who reported
that 30% of newly delivered women were emotionally
distressed. The EPDS identified 61 of the 94 distressed
women as likely depressed, although according to the
DASS-21, 15 of these women were not depressed, but were
rather anxious and/or stressed. As is common practice with
the use of the EPDS as a screening tool, an index of the
severity of depression is required. However, in practice, if
a depression scale (in this case the DASS-21 depression
scale) had been the only measure used to assess the sever-
ity of the 80 EPDS-identified women, these 15 non-
depressed–but clearly, distressed–women would have
potentially been overlooked for further investigation and
assistance.
The EPDS identified 10 out of 18 anxious women, and 21
out of 23 anxious-depressed women, showing support for
the previous research findings concerning an anxiety sub-
scale within the EPDS [16,35,47-49]. The EPDS however,
did not identify 14 women (4%) who were found by the
DASS to have mild and moderate symptoms of depression.
This is surprising given the sensitive cut-off (of over 9)
that was used on the EPDS. However, with the capacity of
the DASS to detect mild cases of depression, these women,
in practice, could have been attended to, and followed up
for worsening symptomatology by the application of the
DASS-21 over time. Of more concern, is that the EPDS, as
a screening tool, did not identify 18 women (6%) who
were distressed (i.e, anxious and/or stressed on the DASS-
21). The implication for these 18 women is that in prac-
tice, they could 'fall through the cracks' due to an over-
reliance on depression being the marker for distress in the
postpartum. Taken together, the findings of this study
demonstrate that a total of 33 women (10% of the total
sample) might have been overlooked if depression had
Table 1: Numbers of women in each scoring category on DASS-21 depression, anxiety and stress scales for each classified group 
(depressed, anxious-depressed, anxious, and stressed), and the number of women with corresponding EPDS identifications
Mild Moderate Severe Extremely Severe No EPDS identification (i.e., unlikely depressed)
Depressed group (N = 38)
on DASS-depression 24 12 1 1
on EPDS-likely depressed 14 9a 11 1 2
Anxious-depressed group (N = 23)
on DASS-depression 3 9 9 2
on EPDS-likely depressed 37 9 2 2 b
on DASS-anxiety 5 8 3 7
on EPDS-likely depressed 48 2 7 2 b
Anxious group (N = 18)
on DASS-anxiety 10 4 1 3
on EPDS-likely depressed 51 1 3 8
Stressed group (N = 15)
on DASS-stress 8 4 3
on EPDS-likely depressed 21 2 1 0
a Missing data for one woman who failed to complete the EPDS.
b The EPDS missed 4 classifications, 2 on depression and 2 on anxiety, which accounted for 2 cases of anxious-depression.BMC Psychiatry 2006, 6:12 http://www.biomedcentral.com/1471-244X/6/12
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been the sole marker upon which postnatal distress was
determined.
The present study not only showed the ability of the
DASS-21 to disentangle classifications of depression, from
anxiety and stress, but also demonstrated its capacity to
identify comorbid classifications. The sub-group of anx-
ious-depressed  women was of particular interest in the
present study as some authors have identified that (non-
postpartum) patients in whom anxiety and depression co-
occur, manifest more severe symptoms [18] are more dif-
ficult to treat [19], show poorer acute and long-term out-
comes [18], and are at increased risk for suicide [20] than
patients with either pure anxiety or depression. It has also
been reported that patients with sub-threshold depression
and anxiety are at a greater risk for developing a threshold
disorder following a psychosocial stressor [50]. In the
present study, the DASS-21 identified 61 women (19%)
to be depressed, of whom 23 (7% of the total sample) were
also  anxious  (anxious-depressed). These anxious-depressed
mothers were found to have significantly higher levels of
depressive symptoms on both the DASS-21 and the EPDS
compared to participants who reached criteria for depres-
sion alone. These findings point to the clinical importance
of detecting this group so that appropriate interventions
can be implemented.
Arguably, new motherhood is one of the most important
life stages requiring the accurate detection and treatment
of distress. The findings of the present study demonstrate
the utility of the DASS-21, in conjunction with the EPDS,
for detecting depression, anxiety and stress as distinct
emotional states; for detecting cases where a combination
of symptoms are present; and for its capacity to detect
mild cases of depression, with reduced likelihood of con-
founding depression with normal concomitants of post-
partum life.
Limitations of the present study
There are a number of limitations of the study that may
restrict its generalizability. Respondents were recruited
from mothers' groups; health centres and doctors' surger-
ies by placing posters encouraging women to collect and
complete a questionnaire concerning their experience of
first time motherhood. Individual women were not
approached directly. Given the non-intrusive data collec-
tion procedure used in this study there was no way of
assessing the representativeness of the women choosing
to volunteer. The high proportion of tertiary educated
women (i.e., two thirds of the sample) may be a reflection
of a self-selection bias, with highly educated women being
more willing to take the time to complete and return the
questionnaire. Further research is needed to replicate this
study using sampling designs that allow a more represent-
ative sample of women from a wider variety of back-
grounds, and socio-economic and educational levels. No
formal diagnostic structured interview was conducted in
this study in order to provide a 'gold standard' against
which to validate the DASS-21 for its use in postnatal pop-
ulations. Further studies are necessary to address this issue
and to also assess the usefulness of the DASS-21 in popu-
lations of antenatal women [10,14,16] and multiparous
women.
Conclusion
The present study points to the need for a broader assess-
ment of distress in the postpartum with a view to preven-
tion and early intervention [10]. The DASS-21 appears to
be a useful tool for broadening the criteria for postnatal
distress, over and above that of depression to include anx-
iety and stress. It may serve as a worthwhile addition to
the widely used EPDS, by providing continuous ratings of
severity on the three negative emotional states of depres-
sion, anxiety, and stress, and by identifying the comorbid-
ity of these states. For as long as the focus of postnatal
maladjustment is on depression, failure to identify and
treat significant symptoms of anxiety and stress may leave
women vulnerable to worsening symptomatology.
Untreated maternal distress can have a substantial impact
on the well-being of the mother, her relationships and her
infant. The DASS-21 is a brief, easy to administer, inven-
tory that may assist practitioners (along with clinical inter-
views) to more effectively assess and treat new mothers
who may be depressed, anxious and/or stressed in the
postpartum.
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